469 Although gut-derived serotonin is unable to cross the BBB, the serotonin precursor (5-hydroxytryptophan) and serotonin derivatives (N-acetylserotonin and melatonin) can cross the BBB to influence the CNS
The clinical trials that produced the impressive 15 to 17% body weight reduction numbers were measured over 68 weeks, not 7 days
How It Works Activates both GLP-1 and GIP receptors for a broader metabolic impact Reduces appetite and increases satiety through two hormonal pathways Enhances insulin sensitivity more aggressively than GLP-1 alone Supports reduction of visceral fat the deep abdominal fat most strongly associated with metabolic disease Improves blood sugar regulation through a dual insulin-stimulating mechanism Clinical Results In the SURMOUNT-1 trial, Tirzepatide produced average weight loss of up to 20% of body weight outperforming Semaglutide in head-to-head comparisons
All patients were 45 years or older, with an initial BMI of 27 kg/m2 or greater and established CV disease (prior myocardial infarction, prior stroke, or peripheral arterial disease)
That is half the tolerance window of Ozempic, and the reason comes down to formulation differences, concentration variations, and the preservative system used in each product
